What market does “Glucagen injection” cover (and which figures you’ll need)
“Glucagen” is a brand name for glucagon injection. Market-share answers usually depend on (1) the country, (2) the time period, and (3) the defined category (for example: “glucagon injection” or “emergency glucagon products”). Without those definitions, published “market share” numbers are often not directly comparable across reports.
Where to find market-share numbers for Glucagen (typical data sources)
Most market-share figures for branded injectables like Glucagen come from paid industry databases and syndicated reports (often used by pharma analysts), such as IQVIA, GlobalData, or similar sources, plus occasional company filings. Public sources may only show revenue for the manufacturer’s branded product—not market-share—unless a report explicitly publishes shares.
Who typically leads the glucagon-injection category
A common pattern in markets for branded injectables is that market share concentrates around the main branded glucagon product(s) and later shifts when competing products are launched or when formularies favor one product. Exact “Glucagen injection” share figures require a specific dataset for:
- the geography (US vs EU vs worldwide),
- the sales measure (units vs revenue),
- and the category scope (all glucagon products vs only emergency kits vs only injections).
If you mean the US: what to look for in sales vs share
If your goal is US market share, the fastest way to get a credible answer is to locate:
- annual or quarterly branded glucagon injection sales by product (units and/or dollar sales),
- the total category size used by the same dataset,
- then compute share = Glucagen sales / total glucagon injection category sales.
This matters because “market share” can change meaning depending on whether the denominator is “all glucagon” or “glucagon injection” only.
Can you tell me the exact Glucagen market-share you want?
To provide the actual percentage (with citations), I need one detail from you:
1) Which region (US, EU, UK, or worldwide)?
2) Which year or timeframe (2023, 2024, last 12 months)?
3) Do you want share by revenue or by units?
4) Confirm the product scope: Glucagen (glucagon injection) only, or include other glucagon formulations?
Reply with those, and I’ll target the specific market-share figure that matches your definition.